
TRANS GENIC GROUP INC. - Investor Relations & Filings
TRANS GENIC GROUP INC. is a biotechnology company that operates through two main business segments: Drug Discovery Support and Investment & Consulting. The Drug Discovery Support division provides comprehensive services across the entire drug development pipeline, from basic research to non-clinical and clinical trials. Core services include the contract production of genetically modified animals, particularly mice, using genome editing technologies like CRISPR/Cas9. The company also specializes in contract antibody production, glycosylation analysis, and the supply of model mice. The Investment & Consulting segment focuses on M&A, business succession, and providing advisory and support services for business revitalization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 訂正有価証券報告書-第27期(2024/04/01-2025/03/31) | 2025-08-01 | Japanese | |
| 訂正臨時報告書 | 2025-07-02 | Japanese | |
| 臨時報告書 | 2025-07-01 | Japanese | |
| 確認書 | 2025-06-30 | Japanese | |
| 内部統制報告書-第27期(2024/04/01-2025/03/31) | 2025-06-30 | Japanese | |
| 有価証券報告書-第27期(2024/04/01-2025/03/31) | 2025-06-30 | Japanese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
11 filings
| |||||
| 7859630 | 訂正有価証券報告書-第27期(2024/04/01-2025/03/31) | 2025-08-01 | Japanese | ||
| 7241592 | 訂正臨時報告書 | 2025-07-02 | Japanese | ||
| 7242344 | 臨時報告書 | 2025-07-01 | Japanese | ||
| 7244210 | 確認書 | 2025-06-30 | Japanese | ||
| 7244204 | 内部統制報告書-第27期(2024/04/01-2025/03/31) | 2025-06-30 | Japanese | ||
| 7244201 | 有価証券報告書-第27期(2024/04/01-2025/03/31) | 2025-06-30 | Japanese | ||
| 48149719 | 2025年3月期 決算短信[日本基準](連結) | 2025-06-16 | Japanese | ||
| 7259223 | 臨時報告書 | 2025-06-13 | Japanese | ||
| 48149720 | 特別損失等の計上による通期連結業績予想の修正及び個別業績の前期実績との差異に関するお知らせ | 2025-06-13 | Japanese | ||
| 7266406 | 臨時報告書 | 2025-04-23 | Japanese | ||
| 48149721 | 2025年3月期 第3四半期決算短信〔日本基準〕(連結) | 2025-02-14 | Japanese | ||
|
2024
4 filings
| |||||
| 7298253 | 確認書 | 2024-11-13 | Japanese | ||
| 7298255 | 半期報告書-第27期(2024/04/01-2025/03/31) | 2024-11-13 | Japanese | ||
| 48149722 | 2025年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結) | 2024-11-12 | Japanese | ||
| 48149723 | 2025年3月期 第1四半期決算短信〔日本基準〕(連結) | 2024-08-09 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
| 2Seventy Bio Inc | TSVT | US | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
| AB-Biotics S.A. | ABB | ES | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
| Able Laboratories Inc | ABRX | US | Professional, scientific and te… |
| ABLYNX | — | BE | Professional, scientific and te… |
TRANS GENIC GROUP INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/13323/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=13323 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing - metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=13323 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=13323 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 13323}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TRANS GENIC GROUP INC. (id: 13323)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.